Showing results (481-490 of 734) with videos related to

Sort By:
Pageof 74
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2015
Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy against Waldenström MacroglobulinemiaIsere Kuiatse, Veerabhadran Baladandayuthapani, Heather Y Lin, et al.
Leukemia & Lymphoma|July 25, 2022
Insurance-based disparities impact survival outcomes in Waldenström macroglobulinemia within the United StatesKaran L Chohan, Jithma P Abeykoon, Stephen M Ansell, et al.
British Journal of Haematology|June 28, 2017
Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapyUmar Farooq, Matthew J Maurer, Carrie A Thompson, et al.
Haematologica|June 16, 2018
Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangementsEllen D McPhail, Matthew J Maurer, William R Macon, et al.
Blood Cancer Journal|April 20, 2013
Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphomaL F Porrata, K M Ristow, T M Habermann, et al.
Leukemia|July 2, 2011
Lenalidomide can be safely combined with R-CHOP (R2CHOP) in the initial chemotherapy for aggressive B-cell lymphomas: phase I studyG S Nowakowski, B LaPlant, T M Habermann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2017
International Assessment of Event-Free Survival at 24 Months and Subsequent Survival in Peripheral T-Cell LymphomaMatthew J Maurer, Fredrik Ellin, Line Srour, et al.
American Journal of Hematology|October 14, 2024
Characteristics and outcomes of incidentally diagnosed diffuse large B-cell lymphoma and implications for cancer screeningSuheil Albert Atallah-Yunes, Matthew J Rees, Raphael Mwangi, et al.
Blood Cancer Journal|July 18, 2021
Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab eraArushi Khurana, Raphael Mwangi, Stephen M Ansell, et al.
JCO Oncology Practice|May 20, 2022
Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort AnalysisChristopher S Strouse, Melissa C Larson, Shawna L Ehlers, et al.
Pageof 74